Eli Grunblatt

499 total citations
11 papers, 268 citations indexed

About

Eli Grunblatt is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Eli Grunblatt has authored 11 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Eli Grunblatt's work include Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Eli Grunblatt is often cited by papers focused on Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). Eli Grunblatt collaborates with scholars based in United States, South Africa and Switzerland. Eli Grunblatt's co-authors include David MacPherson, Nan Wu, Ryan Basom, Keith D. Eaton, Emily Eastwood, Ali H. Ibrahim, Renato Martins, Francesca Milletti, Denny Liggitt and Charles M. Rudin and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and The Journal of Immunology.

In The Last Decade

Eli Grunblatt

7 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli Grunblatt United States	5	161	149	82	46	42	11	268
Robert J. Van Gulick United States	9	129 0.8×	122 0.8×	22 0.3×	29 0.6×	24 0.6×	14	242
Manuel Torres-Diz Spain	6	158 1.0×	75 0.5×	26 0.3×	49 1.1×	32 0.8×	11	218
Sook Kyung South Korea	8	105 0.7×	104 0.7×	18 0.2×	50 1.1×	65 1.5×	29	229
Tong Shu China	8	174 1.1×	87 0.6×	37 0.5×	49 1.1×	16 0.4×	22	251
Zhiyuan Hua China	6	118 0.7×	118 0.8×	20 0.2×	105 2.3×	22 0.5×	7	255
Jun Nie China	11	105 0.7×	266 1.8×	58 0.7×	69 1.5×	149 3.5×	31	392
Jinxiao Liang China	10	218 1.4×	83 0.6×	33 0.4×	100 2.2×	26 0.6×	27	330
Huixing Huang China	6	163 1.0×	36 0.2×	42 0.5×	116 2.5×	26 0.6×	8	241
Mingchao Xie United States	9	65 0.4×	103 0.7×	50 0.6×	28 0.6×	53 1.3×	14	165
Adam B. Sendor United States	3	130 0.8×	134 0.9×	25 0.3×	99 2.2×	53 1.3×	4	322

Countries citing papers authored by Eli Grunblatt

Since Specialization

Citations

This map shows the geographic impact of Eli Grunblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Grunblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Grunblatt more than expected).

Fields of papers citing papers by Eli Grunblatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Grunblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Grunblatt. The network helps show where Eli Grunblatt may publish in the future.

Co-authorship network of co-authors of Eli Grunblatt

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Grunblatt. A scholar is included among the top collaborators of Eli Grunblatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Grunblatt. Eli Grunblatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hippe, Daniel S., Eli Grunblatt, Pritha Chanana, et al.. (2025). In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer. Science Advances. 11(17). eadq7084–eadq7084.

Grunblatt, Eli & Nausheen Akhter. (2025). Cardiovascular complications of cellular immunotherapies and associated risk factors. PubMed. 2(1).

Grunblatt, Eli, Abigail S. Baldridge, Matthew J. Feinstein, et al.. (2025). Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapies. Leukemia & lymphoma. 66(5). 858–868.

Grunblatt, Eli & Matthew J. Feinstein. (2024). Precision Phenotyping of Heart Failure in People with HIV: Early Insights and Challenges. Current Heart Failure Reports. 21(4). 417–427.

Grunblatt, Eli, Nan Wu, Huajia Zhang, et al.. (2020). MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity. Genes & Development. 34(17-18). 1210–1226. 68 indexed citations

Augert, Arnaud, Emily Eastwood, Ali H. Ibrahim, et al.. (2019). Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition. Science Signaling. 12(567). 154 indexed citations

Oktay, Maja H., Esther Adler, Eli Grunblatt, et al.. (2016). The Application of Molecular Diagnostics to Stained Cytology Smears. Journal of Molecular Diagnostics. 18(3). 407–415. 20 indexed citations

Dougherty, Max L., John Lazar, Jason C. Klein, et al.. (2016). Genome sequencing in a case of Niemann–Pick type C. Molecular Case Studies. 2(6). a001222–a001222. 10 indexed citations

Jung, Hyunggu, Eli Grunblatt, Lucy Lu Wang, et al.. (2016). Development of a Novel Markov Chain Model for the Prediction of Head and Neck Squamous Cell Carcinoma Dissemination.. PubMed. 2016. 1832–1839. 3 indexed citations

10.

Goldfarb, Shari, Giuliano Bedoschi, Eli Grunblatt, et al.. (2015). The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses.. Journal of Clinical Oncology. 33(15_suppl). 9522–9522. 1 indexed citations

11.

McNally, Jonathan P., Eileen E. Elfers, Catherine E. Terrell, et al.. (2013). Eliminating Encephalitogenic T Cells without Undermining Protective Immunity. The Journal of Immunology. 192(1). 73–83. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact